ASKA Pharmaceutical Holdings Co., Ltd.
あすか製薬ホールディングス株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4886
FY2025 · 2026-03-31
| Gross margin | 48.0% |
| Operating margin | 8.2% |
| Net margin | 7.6% |
| Return on equity | 8.5% |
| Return on assets | 4.8% |
| Revenue growth (YoY) | 10.9% |
| EPS (basic) | ¥191.12 |
| EPS growth (YoY) | 6.2% |
| Current ratio | 2.76x |
| Equity ratio | 56.9% |
| Book value / share | ¥2,477.81 |
| Free cash flow | 3,754 M |